BLACK BOX WARNING REGARDING ANTIDEPRESSANT USE IN CHILDREN
POSSIBLE CAUSES OF INCREASED SUICIDALITY IN CHILDREN TAKING
ANTIDEPRESSANTS
SSRIS AND CHILDREN
THE LINK BETWEEN DEPRESSION AND SUICIDE
CONTROVERSY AND CONSEQUENCES OF THE FDA WARNING
BLACK BOX WARNING REGARDING ANTIPSYCHOTIC USE IN THE ELDERLY
MEDICATIONS RECEIVING A BLACK BOX WARNING IN THE ELDERLY

GENERAL UPDATES IN DSM-5
SAMPLE DSM-5 DIAGNOSTIC DOCUMENTATION

DSM-5 TYPES
BLACK BOX WARNING REGARDING ANTIDEPRESSANT USE IN CHILDREN
ANTIDEPRESSANTS
Selective Serotonin Reuptake Inhibitors (SSRIs)
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Serotonin Antagonist and Reuptake Inhibitors (SARIs)
Other Medications
Monoamine Oxidase Inhibitors (MAOIs)
Tricyclic Antidepressants (TCAs)

DSM-5 TYPES
UNSPECIFIED BIPOLAR AND RELATED DISORDERMOOD STABILIZERS
Lithium
Anticonvulsants
Atypical Antipsychotics (Second Generation)
Other Medications

ANXIOLYTICS
Benzodiazepines
Non-Benzodiazepine Medications
Antidepressants
Alpha-Blockers
Beta-Blockers
Anticonvulsants
Antipsychotics

CHANGES IN DSM-5
MEDICATIONS
CNS Stimulants (amphetamine- and methylphenidate-based)
Nonstimulants

SYMPTOMS OF PSYCHOSIS
PSYCHOTIC DISORDERS MANAGEMENT
BLACK BOX WARNING REGARDING ANTIPSYCHOTIC USE IN THE ELDERLY
MEDICATIONS
Atypical Antipsychotics (Second Generation)
Typical Antipsychotics (First Generation)

DISORDERS/SIDE EFFECTS CAUSED BY PSYCHIATRIC MEDICATION
Extrapyramidal Symptoms (EPS)
DISORDERS EXACERBATED BY PSYCHIATRIC MEDICATION
Restless Leg Syndrome
Tourette Syndrome
Sexual Dysfunction
Weight Gain

HYPNOTICS
BENZODIAZEPINE HYPNOTICS
NON-BENZODIAZEPINE HYPNOTICS

DSM-5 CHANGES
DRUGS OF ABUSE

CHANGES IN DSM-5
TREATMENT
NON-BENZODIAZEPINE HYPNOTICS

FDA PREGNANCY RATINGS
MEDICATION USED IN PREGNANCY AND LACTATION
PREGNANCY-RELATED PSYCHIATRIC DISORDERS
Postpartum Blues
Postpartum Depression
Postpartum Psychosis
PRINCIPLES OF MANAGEMENT

BLACK BOX WARNING REGARDING ANTIDEPRESSANT USE IN CHILDREN
MEDICATIONS
CLOMIPRAMINE ELDERLY PATIENTS
Black Box Warning Regarding Antipsychotic Use in the Elderly
Medications
Treatment of Agitation in the Elderly

HEPATIC DISORDER
RENAL DISORDER
HIV
Important Notes Regarding Use of Psychotropic Drugs in HIV 256

PSYCHIATRIC MEDICATION-RELATED EMERGENCIES (NMS, SEROTONIN SYNDROME) SUICIDE
Alcohol Dependence: 2% Risk Factors
Management
Prevention
AGITATION AND VIOLENCE
Causes and Risk Factors
Management
Prevention
PSYCHIATRIC MEDICATION-RELATED EMERGENCIES
Neuroleptic Malignant Syndrome (NMS)
Serotonin Syndrome

COMPLEX PTSD CHANGES IN DSM-5
MANAGEMENT
Psychotherapeutic Approaches
Pharmacological Treatment

DSM-5 TYPES
TESTING
MANAGEMENT
Anorexia Nervosa
Binge Eating Disorder
Bulimia Nervosa
PREVENTION

CATEGORIZATION
MANAGEMENT
Therapy
Dialectic behavior therapy Medication
Antisocial Personality Disorder

FOCAL ELECTRICAL ALTERNATING CURRENT THERAPY (FEAT)
ELECTROCONVULSIVE THERAPY (ECT)
VAGUS NERVE STIMULATION (VNS)
REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS)
MAGNETIC SEIZURE THERAPY (MST)
DEEP BRAIN STIMULATION (DBS)
FISHER WALLACE STIMULATOR
TRANSCRANIAL DIRECT CURRENT STIMULATION (TDCS)
FOCAL ELECTRICAL ALTERNATING CURRENT THERAPY (FEAT)
CRANIAL ELECTROTHERAPY STIMULATION (CES)
GAMMACORETM NVNS DEVICE

FOCAL ELECTRICAL ALTERNATING CURRENT THERAPY (FEAT)
PSYCHIATRIC DISORDERS TREATED WITH ALTERNATIVE MEDICATION
CLINICAL GUIDELINES
COMMON CAMS
DHEA (Dehydroepiandrosterone)
Folate and Vitamin B12
Gingko
Inositol
Kava
Melatonin
Omega-3 Fatty Acids
SAMe (S-Adenosylmethionine)
St. John’s Wort
Valerian

STUDIES, TRIALS, AND NEWER MODALITIES
Drug Trials
Future Medications

INTRODUCTION TO DIGITAL PSYCHIATRY
Advantages and disadvantages
What does the clinician need to know about digital psychiatry?
Websites
Messaging services
Mobile apps
GiTelepsychiatryngko

HOW TO CHOOSE AN APP?
FDA Approved Apps and Devices
Other apps and devices

NEUROPSYCHIATRIC SYMPTOMS OF COVID-19
THE IMPACT OF COVID-19 PANDEMIC ON ECONOMY
The effect of economic hardships on mental health
DIRECT IMPACT OF PANDEMIC REGULATIONS ON MENTAL HEALTH
ETIOLOGY OF PANDEMIC-INDUCED NEGATIVE MENTAL HEALTH OUTCOMES
THE PREVALENCE OF NEGATIVE MENTAL HEALTH OUTCOMES IN THE UNITED STATES
Negative Mental outcomes in different populations
Prevention of pandemic-related mental disorders
IMPLICATIONS FOR THE FUTURE

CANNABIS DERIVATES
Cannabidiol
Dronabinol
Nabilone

INTRODUCTION
BACKGROUND AND EPIDEMIOLOGY
Types of Opioids
Mechanism of Action
Opioid Use Disorder
Opioid Overdose
ROLE OF PARAMEDIC AND POLICE AMIDST THE CRISIS
Opioid Prescription Policies and future directions
CONCLUSION
DRUGS USED FOR OPIOID USE DISORDER
Buprenorphine
Buprenorphine and Naloxone
Levacetylmethadol
Lofexidine
Methadone
Naltrexone
Vivitrol